DRE will work with David C. Fajgenbaum, MD, MBA, MSc, and his team of researchers to use DRE software platforms for the COvid19 Registry of Off-label and New Agents (CORONA), in identifying and analyzing all COVID-19 treatments to prioritize clinical trials and support physicians in providing the best possible care for their patients with COVID-19 December 16, 2020, 10:00 AM […]
AI-driven healthcare technology leader selected to participate in global initiative to better protect the world against health emergencies SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE announced today that it has been selected as a Member of The Trinity Challenge. The Trinity Challenge was launched in September 2020 by Dame Sally Davies, the Master of Trinity College, Cambridge, and former […]
Medical Strategy Advisory Board (“MSAB”) to advise DRE on the convergence of expert AI-enabled technology in healthcare and the exponential growth of clinical information October 19, 2020 10:00 AM Eastern Daylight Time SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE is pleased to welcome four new members to its MSAB. They join Chair, Ameet Nathwani, MD, MRCP, DipPharmMed, MBA […]
Ameet Nathwani, MDChairman, Medical Strategic Advisory Board With more than 25 years of experience in the pharmaceutical industry, Dr. Nathwani was most recently an Executive Committee member at Sanofi AG, as Chief Medical Officer (CMO), Head of Medical and Chief Digital Officer (CDO), responsible for enhancing Sanofi’s strategy to integrate digital technologies and medical science […]
SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence (“DRE”) has developed new tools for automated network meta-analysis, to now be used in the hunt for the most effective treatments for COVID-19. Clinical trial data is continuously emerging that can now be aggregated in real time using DRE’s DOC Analytics™ platform. Read more…
SANTA MONICA, Calif.–(BUSINESS WIRE)–Doctor Evidence (DRE) has updated their newly launched DOC Analytics™ (“Digital Outcome Conversion”) platform with industry standard network meta-analysis (NMA) capabilities. DOC Analytics™ provides immediate quantitative insights into the universe of medical information using artificial intelligence/machine learning (AI/ML) and natural language processing (NLP). With the addition of indirect treatment comparison and landscape analysis using NMA, DOC Analytics™ is a […]
SANTA MONICA, Calif.–(BUSINESS WIRE)–DRE is pleased to welcome Joe Boystak as Chairman of the Board and Ameet Nathwani, MD, as Chairman of its newly formed Medical Strategy Advisory Board (MSAB). These enhancements to the Company reflect the expanded need for keen guidance in this unprecedented time of convergence between expert AI-enabled technology in healthcare and […]
SANTA MONICA, Calif., May 19, 2020 /PRNewswire/ — Doctor Evidence (DRE), a leading Artificial Intelligence-powered SaaS healthcare insights company, has launched its revolutionary DOC (“Digital Outcome Conversion”) Analytics™ platform. DOC Analytics™ is a culmination of over 10-years of R&D and product development. In DOC Analytics™, users can ask natural language medical questions and get precise search results that are powered by DRE’s DOC […]
SANTA MONICA, Calif., March 17, 2020 /PRNewswire/ — Doctor Evidence (“DRE”) is focusing its AI-enabled medical search engine on the COVID-19 medical literature and daily emerging breaking research. Today, as requested by The White House Office of Science and Technology Policy and in response to researchers call for AI machine-readable technology to address the fast evolving Coronavirus literature, […]
SANTA MONICA, Calif., June 19, 2019 /PRNewswire/ — Doctor Evidence, a global health technology and consulting company in biomedical research, releases new updates and an interactive user interface for the DOC Search platform on June 24th. DOC Search was designed to empower both novice and experienced researchers with a user-friendly turnkey solution to independently conduct rapid literature reviews and […]